Therefore, lung cancer cells with simultaneous LKB1 inactivation and KRAS mutation are likely to exhibit greater glucose uptake and consumption, contributing to their rapid tumor growth and suppression of intratumor effector T-cell activity (Figure 3A). Here, STK11 is linked to lung cancer.